Literature DB >> 21878831

H1N1 hemagglutinin-inhibition seroprevalence in Emergency Department Health Care workers after the first wave of the 2009 influenza pandemic.

Swati Kumar1, Jiang Fan, Marlene Melzer-Lange, Jessica Trost, Peter L Havens, Rodney E Willoughby, Michael J Chusid, Kelly J Henrickson.   

Abstract

STUDY
OBJECTIVE: The 2009 H1N1 pandemic (H1N1pdm) virus has been associated with high rates of asymptomatic infections. Existing influenza infection control policies do not address potential transmission through exposure to asymptomatic infected individuals in health care settings. We conducted a seroprevalence study of H1N1pdm infection to determine whether health care workers (HCWs) in the emergency department showed increased evidence of infection during the first wave of the pandemic than that previously reported in adults in the community.
METHODS: Blood samples and demographic and clinical data were collected from eligible emergency department HCWs. Subjects' sera were tested for presence of antibodies specific for seasonal H1N1 and H1N1pdm viruses by hemagglutination-inhibition assay.
RESULTS: One hundred eight subjects were enrolled, of which 20 (18.5%) were seropositive for H1N1pdm and 52 (48%) for seasonal H1N1. The median age of H1N1pdm-seropositive subjects was 32 years (range, 24-59 years). Of H1N1pdm-seropositive subjects, 35% were asymptomatic. Rates of H1N1pdm detection in HCWs (18.5%) were significantly higher than those observed previously in an identical age cohort in the community (2.6%, n = 262).
CONCLUSIONS: The higher serodetection rates in adults observed in the current study suggest potentially significantly more frequent infections in HCWs than in the general population. Further investigations are needed to ascertain the relative incidence of influenza infections in HCWs and non-HCWs, to study influenza transmission by asymptomatic infected subjects and ascertain the burden of such transmission in health care settings.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21878831     DOI: 10.1097/PEC.0b013e31822c125e

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  6 in total

1.  Technical guidelines for the application of seasonal influenza vaccine in China (2014-2015).

Authors:  Luzhao Feng; Peng Yang; Tao Zhang; Juan Yang; Chuanxi Fu; Ying Qin; Yi Zhang; Chunna Ma; Zhaoqiu Liu; Quanyi Wang; Genming Zhao; Hongjie Yu
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Effects of vaccine program against pandemic influenza A(H1N1) virus, United States, 2009-2010.

Authors:  Rebekah H Borse; Sundar S Shrestha; Anthony E Fiore; Charisma Y Atkins; James A Singleton; Carolyn Furlow; Martin I Meltzer
Journal:  Emerg Infect Dis       Date:  2013-03       Impact factor: 6.883

Review 3.  Emergency physician risk of occupational mortality: A scoping review.

Authors:  Craig Goolsby; Vidya Lala; Riley Gebner; Nicole Dacuyan-Faucher; Nathan Charlton; Keke Schuler
Journal:  J Am Coll Emerg Physicians Open       Date:  2021-10-04

4.  Infection in Health Personnel with High and Low Levels of Exposure in a Hospital Setting during the H1N1 2009 Influenza A Pandemic.

Authors:  Carmen Sandoval; Aldo Barrera; Marcela Ferrés; Jaime Cerda; Javiera Retamal; Adolfo García-Sastre; Rafael A Medina; Tamara Hirsch
Journal:  PLoS One       Date:  2016-01-22       Impact factor: 3.240

Review 5.  The Occupational Risk of Influenza A (H1N1) Infection among Healthcare Personnel during the 2009 Pandemic: A Systematic Review and Meta-Analysis of Observational Studies.

Authors:  Janna Lietz; Claudia Westermann; Albert Nienhaus; Anja Schablon
Journal:  PLoS One       Date:  2016-08-31       Impact factor: 3.240

6.  Antibody response to influenza A(H1N1)pdm09 among healthcare personnel receiving trivalent inactivated vaccine: effect of prior monovalent inactivated vaccine.

Authors:  Manjusha Gaglani; Sarah Spencer; Sarah Ball; Juhee Song; Allison Naleway; Emily Henkle; Sam Bozeman; Sue Reynolds; Wendy Sessions; Kathy Hancock; Mark Thompson
Journal:  J Infect Dis       Date:  2013-12-19       Impact factor: 5.226

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.